title: [Agreements and disagreements among the main clinical practice guidelines].
abstract: Diabetes mellitus has an enormous health and social impact and its incidence is rising exponentially in the industrialized world as a result of unhealthy lifestyles. In the last few years, research in this field has increased, leading to the development of new drugs and new indications. Consequently, numerous updates of clinical practice guidelines for diabetes have been published in the last 12 months, which provide health professionals with an up-to-date view of therapeutic possibilities. The present article reviews the guidelines with the greatest scientific impact and discusses areas of agreement and disagreement among these documents.
authors.affiliation: Centro de Salud Rosa Luxemburgo, San Sebastián de los Reyes, Madrid, España. Electronic address: acalderonmontero@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Calderón Montero
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D015195:Drug Design; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic
chemical_list: D007004:Hypoglycemic Agents
keywords: Clinical practice guidelines; Diabetes mellitus tipo 2; Glucose-lowering therapy; Guías de práctica clínica; Tratamiento del riesgo cardiovascular; Tratamiento hipoglucemiante; Treatment of cardiovascular risk; Type 2 diabetes mellitus